Filter Results:
(47)
Show Results For
- All HBS Web
(168)
- News (47)
- Research (98)
- Events (1)
- Multimedia (1)
- Faculty Publications (61)
Show Results For
- All HBS Web
(168)
- News (47)
- Research (98)
- Events (1)
- Multimedia (1)
- Faculty Publications (61)
Sort by
- 20 Aug 2014
- News
With No Time to Lose
an effective biomarker—a kind of test that could measure the progression of ALS over a short period of time—did not yet exist. Without it, drug trials relied on longer, more costly observations of disease... View Details
Keywords: Margie Kelley
- 01 Jun 2003
- News
Ruling from the Bench
notorious criminals. Presiding over complex, multidefendant trials at the height of the 1980s crack cocaine epidemic, Snyder stared down members of the “Wild Cowboys” drug gang like Daniel (“Fat Danny”)... View Details
- 01 Dec 2013
- News
Your Own Medicine
says. "That's just unheard of." If all goes well, the next move could be trials for FDA approval. And HT-100 is just one of the drugs that DART is involved in. It is funding a cardiac View Details
- 01 Jun 2000
- News
The Business of Biotech
currently has drugs in clinical trials for mela-noma and breast cancer, hopes to have its first products on the market as early as 2004. "I think we're going to see more people in the next decade who are... View Details
Keywords: Julia Hanna
- 01 Dec 2019
- News
The Race Against Resistance
people die as a result. And yet, there are only 42 antibiotics currently in clinical development, and typically only 20 percent of infectious disease drugs that enter phase 1 clinical trials will receive FDA... View Details
Keywords: Lisa Scanlon Mogolov
- 01 Mar 2016
- News
Off Script
(Thinkstock) Prescription drug spending increased by more than 13 percent in the United States in 2014, raising health insurance premiums and the ire of consumers and politicians. The reasons behind the rise are many, including the high... View Details
- 04 Sep 2019
- News
Accelerating Scientific Discovery
reduce human disease and suffering influences his work as a health care economist and researcher. “I imagine a world where we have treatments, ideally cures, for diseases where right now we have nothing,” he says. “So the big questions that motivate me are, what are... View Details
Keywords: Jennifer Gillespie
- 01 Mar 2009
- News
A New Approach to Health-Care Reform
companies, complete and accurate patient data would help in screening participants in drug trials and make it possible to track and troubleshoot unexpected problems that show up after a View Details
- 01 Dec 2018
- News
Case Study: Your Data, Your Health
early detection of gynecological diseases. The Oakland-based company completed its second clinical trial and is now raising Series A funding. Its initial indications focus on identifying conditions that contribute to infertility, such as... View Details
Keywords: Jen McFarland Flint
- 04 Sep 2019
- News
Advancing Diagnostics that Can Save Lives
who spent six years commercializing drugs and diagnostics in East and West Africa before earning her MBA. “There are frequently delays in diagnosis, where the turnaround time for a biopsy could be several weeks or months.” That lag time,... View Details
Keywords: Susan Young
- 05 May 2020
- News
“Walking a Tightrope”
Kristof, most of which have focused on poverty in developing countries. But in the Pulitzer Prize-winning duo’s latest book, Tightrope: Americans Reaching for Hope, they turn their lens on working class communities in the United States—communities that have been... View Details
- 01 Jun 2011
- News
The Best-Laid Plans
in on a treatment for age-related macular degeneration, a leading cause of blindness. In October 2009 the company entered into licensing and purchase option agreements with Alcon, which is now taking Potentia’s drug candidate through... View Details
- 23 Jan 2019
- News
The Promise of Personalized Medicine
and a 501(c)(3) called Cure Rare Disease. With the foundation, Horgan is trying to build something radical: A model for personalizing drug development, with the hopes of saving not only his brother but countless others. READ MORE Morrell:... View Details
- 01 Dec 2009
- News
Seven Honored with Alumni Achievement Award
Merck, Gillette, and Searle, Kathy Giusti was diagnosed in 1996 with multiple myeloma, a rare and incurable blood cancer. She then founded the Multiple Myeloma Research Foundation and the Multiple Myeloma Research Consortium, organizations that have revolutionized... View Details
- 25 Feb 2020
- News
Alumni and Faculty Books for March 2020
solve our nation's drug epidemic. These accounts, illustrated with searing images by the award-winning photographer Lynsey Addario, provide a picture of working-class families needlessly but profoundly damaged as a result of decades of... View Details
- 03 Mar 2017
- News
Big Blue’s Big Bet
of the UNC Lineberger Comprehensive Cancer Center. Besides reading all the medical journals, Watson could inform doctors of when certain drug trials began and when others ended; it could also sequence a... View Details
Keywords: Paul Kix; illustrations by Dan Page
- 01 Dec 1996
- News
An Entrepreneurial Journey
knows, an inspirational business concept is only the beginning of a long and complicated journey marked by unexpected obstacles at every turn. The successful entrepreneur must possess an unshakable belief in his or her goal and - as the View Details
- 15 Dec 2015
- News
The Year in Ideas 2015
to something big. After a second field study, Solomon and Hillerstrom launched NeuroPhage. In tests on mice, the drug they developed improved both memory and cognitive abilities. “We believe it can identify harmful aggregates in the... View Details
- 01 Jun 2018
- News
June 2018 Alumni and Faculty Books
damaged the US’s social psyche, as did widespread drug use and chemical dependency. Vivid pictures of violence in Vietnam on TV plus incessant riots in major US cities began to blur the differences between crime, punishment, and... View Details
- 01 Dec 2013
- News
Curing Health Care
Massachusetts Governor Deval Patrick joked in his speech.) Related Links A Blueprint for Patient-Driven Drug Development Gene Williams (MBA 1987) Blavatnik Gift Accelerates Biomedical Advances Oscar Winners Even worse is what... View Details